LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Home・Aktien・Champions Oncology Inc

C
Champions Oncology Inc

Geschlossen

BrancheGesundheitswesen

6.47 3.03

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.44

Max

6.47

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.4M -466K
Verkäufe	1.6M 14M
KGV Branchendurchschnitt	29.81 77.671
Gewinnspanne	-3.33
Angestellte	213
EBITDA	1.5M -527K

Dividenden
By Dow Jones
Nächstes Ergebnis	15. Dez. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-28M 86M
Vorheriger Eröffnungskurs	3.44
Vorheriger Schlusskurs	6.47

Nachrichtenstimmung

By Acuity

26%

74%

51 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

5.77 / 7.61 Unterstützung & Widerstand

Champions Oncology Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Dez. 2025, 22:53 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13. Dez. 2025, 00:04 UTC

Akquisitionen, Fusionen, Übernahmen

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14. Dez. 2025, 23:46 UTC

Market Talk

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14. Dez. 2025, 23:36 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14. Dez. 2025, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Take Full Control of US$101M Copper Miner Alta

14. Dez. 2025, 22:02 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14. Dez. 2025, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14. Dez. 2025, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14. Dez. 2025, 21:59 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Acquire Remaining 64% of Alta Copper

14. Dez. 2025, 17:00 UTC

Ergebnisse

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14. Dez. 2025, 08:30 UTC

Akquisitionen, Fusionen, Übernahmen

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13. Dez. 2025, 16:48 UTC

Akquisitionen, Fusionen, Übernahmen

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13. Dez. 2025, 08:00 UTC

Akquisitionen, Fusionen, Übernahmen

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13. Dez. 2025, 07:00 UTC

Akquisitionen, Fusionen, Übernahmen

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13. Dez. 2025, 00:24 UTC

Akquisitionen, Fusionen, Übernahmen

Want a Piece Of SpaceX? -- Barrons.com

12. Dez. 2025, 23:49 UTC

Akquisitionen, Fusionen, Übernahmen

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12. Dez. 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12. Dez. 2025, 22:32 UTC

Ergebnisse

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. Dez. 2025, 20:45 UTC

Ergebnisse

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12. Dez. 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12. Dez. 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12. Dez. 2025, 19:23 UTC

Ergebnisse

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12. Dez. 2025, 18:35 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12. Dez. 2025, 18:33 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12. Dez. 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12. Dez. 2025, 17:49 UTC

Ergebnisse

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12. Dez. 2025, 17:34 UTC

Akquisitionen, Fusionen, Übernahmen

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Peer-Vergleich

Kursveränderung

Champions Oncology Inc Prognose

Rating-Konsens

By TipRanks

Buy

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Champions Oncology Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

5.77 / 7.61Unterstützung & Widerstand

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Stimmung

By Acuity

51 / 374 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.